Alan Sachs

Alan Sachs

Direktör/Styrelseledamot på QUANTERIX CORPORATION
Health Technology
Consumer Services
Commercial Services

Profil

Alan B. Sachs is currently an Independent Director at Quanterix Corp.
since 2025.
Former positions include Chief Medical Officer at Thermo Fisher Scientific, Inc. from 2021 to 2025, Chief Scientific Officer at Life Technologies Corp.
from 2012 to 2016, Vice President-Basic Research at Sirna Therapeutics, Inc. in 2011, Vice President-Molecular Profiling at Rosetta Inpharmatics LLC from 2002 to 2004, VP-Exploratory & Translational Sciences at Merck Research Laboratories Massachusetts LLC in 2002, Director-Clinical Genomics at Merck & Co., Inc., Director at Odyssey Thera, Inc., Member at Massachusetts Institute of Technology from 1989 to 1992, Associate Professor at the University of California, Berkeley, and Fellow at Whitehead Institute for Biomedical Research.
Education includes a doctorate from Stanford University, an undergraduate degree from Cornell University, and a doctorate from Stanford University School of Medicine.

Aktiva positioner av Alan Sachs

FöretagPositionStart
QUANTERIX CORPORATION Direktör/Styrelseledamot 2025-11-20

Tidigare kända positioner av Alan Sachs

FöretagPositionSlut
THERMO FISHER SCIENTIFIC, INC. Teknisk/Vetenskaplig/F&U Direktör 2025-06-01
Teknisk/Vetenskaplig/F&U Direktör 2016-01-01
Företagsledare/Principal -
Företagsledare/Principal 2002-06-01
Företagsledare/Principal 1992-01-01
Se detaljerna i Alan Sachss erfarenhet

Alan Sachss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

96

Första gradens relationer

14

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag14

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Consumer Services

  1. Börsen
  2. Insiders
  3. Alan Sachs